title: Effect of iron intake on iron status: a systematic review and meta-analysis of randomized controlled trials.
abstract: BACKGROUND
  The response of status biomarkers to an increase in iron supply depends on several physiologic and environmental factors, which make it difficult to predict the outcome of an intervention.
  
  
  OBJECTIVE
  We assessed effects of baseline iron status, sex, menopausal status, duration of intervention, iron form, and daily dose on the change in iron status in response to iron supplementation.
  
  
  METHODS
  A systematic review of randomized controlled trials (RCTs) of iron-supplementation and -fortification trials that assessed effects on hemoglobin, serum ferritin (SF), soluble transferrin receptor, or body iron was conducted. Subgrouping and straight-line and curved metaregression were used to describe the magnitude and dose-responsiveness of effect modifiers with respect to changes in status.
  
  
  RESULTS
  Forty-one RCTs were included; none of the RCTs were judged at low risk of bias. Random-effects meta-analyses showed that iron supplementation significantly improved iron status but with high levels of heterogeneity. Metaregression explained approximately one-quarter of between-study variance in effect size. There were clear effects on SF with study duration (increase in SF concentration/wk: 0.51 μg/L; 95% CI: 0.02, 1.00 μg/L; P = 0.04) and dose (increase in SF concentration/g Fe: 0.10 μg/L; 95% CI: 0.01, 0.20 μg/L; P = 0.036) and on hemoglobin concentrations with baseline iron status [-0.08 g/dL (95% CI: 0.15, 0.00 g/dL) per 10-μg/L increase in baseline SF concentration; P = 0.02]. Insufficient data were available to assess effects on body iron, sex, or menopausal status.
  
  
  CONCLUSIONS
  Quantitative relations between baseline iron status, study duration, and iron dose on changes in iron-status biomarkers, which were generated from the meta-analyses, can be used to predict effects of trials of iron supplementation and fortification and to design iron-intervention programs.
authors.affiliation: Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
authors.forename: Amelie
authors.initials: A
authors.lastname: Casgrain
authors.forename: Rachel
authors.initials: R
authors.lastname: Collings
authors.forename: Linda J
authors.initials: LJ
authors.lastname: Harvey
authors.forename: Lee
authors.initials: L
authors.lastname: Hooper
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Fairweather-Tait
mesh_terms: D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000178:diet therapy / Q000517:prevention & control; D015415:Biomarkers / Q000097:blood; D019587:Dietary Supplements; D005260:Female; D005527:Food, Fortified; D006801:Humans; D019266:Iron, Dietary / Q000008:administration & dosage*; D008297:Male; D009752:Nutritional Status; D017698:Postmenopause; D017697:Premenopause; D016032:Randomized Controlled Trials as Topic; D012727:Sex Characteristics
chemical_list: D015415:Biomarkers; D019266:Iron, Dietary